Thank you and everybody, for joining us this morning and this evening for those joining from overseas. My name is Kyahn Williamson. I'm the SVP of Investor Relations and Corporate Communications at ...
Strategic collaborations and high-profile board appointments reinforce Telix Pharmaceuticals' growth trajectory. Read why TLX ...
Telix Pharmaceuticals (NASDAQ:TLX) updated on Tuesday its commercial and operational performance for the third quarter of fiscal 2025. Telix reported third-quarter revenue of $206 million, up 53% year ...
Feb 21 (Reuters) - Shares of Australia's Telix Pharmaceuticals (TLX.AX), opens new tab jumped to a record high on Friday after the company forecast bumper revenue for the current year and logged a ...
Yesterday afternoon, Telix Pharmaceuticals Ltd (ASX: TLX) reported US$206 million in unaudited group revenue for Q3 2025, up 53% year-over-year, and upgraded its FY 2025 revenue guidance to US$800â ...
Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia’s largest such offering this year. The company’s ...
Hosted on MSN
Telix Pharma keeps guidance after strong Q1 result
The news: Telix Pharmaceuticals has reaffirmed its full-year revenue guidance after posting strong first-quarter growth generated from its prostate cancer imaging product Illuccix. The numbers: Telix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results